r-3750
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2023 (NCT05666960)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07076290 | Phase 1 | Nov 1, 2025 | Rise Therapeutics LLC |
| NCT05666960 | Phase 1 | Jan 31, 2023 | Mayo Clinic, Rise Therapeutics LLC, University of Colorado, Denver |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rise Therapeutics LLC | For profit | 2 | 2 | 1 | 2023 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1